Epidemiology of paraneoplastic neurologic syndromes and autoimmune encephalitides in France.
Journal
Neurology(R) neuroimmunology & neuroinflammation
ISSN: 2332-7812
Titre abrégé: Neurol Neuroimmunol Neuroinflamm
Pays: United States
ID NLM: 101636388
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
received:
22
05
2020
accepted:
17
07
2020
entrez:
28
8
2020
pubmed:
28
8
2020
medline:
5
10
2021
Statut:
epublish
Résumé
To determine the observed and expected incidence rates of paraneoplastic neurologic syndromes (PNSs) and autoimmune encephalitides (AEs) diagnosed in France between 2016 and 2018, we conducted a population-based epidemiologic study. Observed incidence rates were stratified by sex, age groups, region of care, year of diagnosis, and disease subgroups. National expected incidence rates were calculated based on rates obtained in the area directly adjacent to the Reference Center using a mixed Poisson model and compared with observed incidence rates. Six hundred thirty-two patients with definite PNS or AE met the inclusion criteria. The observed incidence rate of definite PNS and AE in France was 3.2 per million person-years (CI There was a significant widespread year-to-year increase in the incidence of diagnoses registered with the Reference Center for all subgroups of PNS and AE studied. The national observed incidence rate is likely underestimated due to underdiagnosis and underreporting.
Identifiants
pubmed: 32847939
pii: 7/6/e883
doi: 10.1212/NXI.0000000000000883
pmc: PMC7455315
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.
Références
Brain Dev. 2018 Jun;40(6):473-479
pubmed: 29599011
Rev Epidemiol Sante Publique. 2005 Apr;53(2):205-8
pubmed: 16012378
Neurology. 2019 Sep 10;93(11):e1093-e1103
pubmed: 31405908
Neurology. 2016 Oct 4;87(14):1449-1456
pubmed: 27590293
J Neurol Neurosurg Psychiatry. 2012 Feb;83(2):195-8
pubmed: 21933952
J Neurol Neurosurg Psychiatry. 2020 Jul;91(7):772-778
pubmed: 32312871
Stat Med. 1989 May;8(5):551-61
pubmed: 2657958
Can J Neurol Sci. 2018 Sep;45(5):540-544
pubmed: 29936915
Lancet Neurol. 2008 Dec;7(12):1091-8
pubmed: 18851928
Ann Neurol. 2018 Jan;83(1):166-177
pubmed: 29293273
J Neurol. 2020 Jan;267(1):26-35
pubmed: 31552550
J Neurol Neurosurg Psychiatry. 2004 Aug;75(8):1135-40
pubmed: 15258215
J Clin Neurol. 2016 Jan;12(1):1-13
pubmed: 26754777
Arch Dis Child. 2015 Jun;100(6):521-6
pubmed: 25637141
Neurol Neuroimmunol Neuroinflamm. 2020 Mar 13;7(3):
pubmed: 32170044
Neurology. 2019 Feb 26;92(9):e964-e972
pubmed: 30674590
Brain. 2013 Oct;136(Pt 10):3151-62
pubmed: 24014519
Cerebellum. 2020 Oct;19(5):715-721
pubmed: 32592031
Neurol Neuroimmunol Neuroinflamm. 2019 Aug 7;6(6):
pubmed: 31454760
Neurology. 2011 Jul 12;77(2):179-89
pubmed: 21747075
Lancet Neurol. 2016 Apr;15(4):391-404
pubmed: 26906964
J Neurol. 2020 Jul;267(7):2154-2156
pubmed: 32451614